Nasserzare Sania, Lehrner Johann
Department of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria.
Wien Klin Wochenschr. 2025 Mar;137(5-6):172-181. doi: 10.1007/s00508-024-02431-4. Epub 2024 Sep 18.
Thyroid hormones may affect olfaction in different stages of cognitive impairment: subjective cognitive decline (SCD), non-amnestic (naMCI) and amnestic mild cognitive impairment (aMCI). Additionally, biometric parameters, depression, and neuropsychological performance are considered as possible influencing factors.
A retrospective single-center data analysis was conducted during the observation period 2001-2023, with n = 495 (52.3% female) SCD, naMCI and aMCI subjects, aged ≥50 years, at the General Hospital of Vienna.
The criterion olfactory function was objectively measured by Sniffin' Sticks© odor identification and subjectively through the Assessment of Self-Reported Olfactory Functioning test. Serum thyroid hormone levels, mainly thyroid-stimulating hormone, as well as T3, T4, fT3, and fT4, were used to assess thyroid function. Statistical analyses using IBM SPSS® 29.0.0 covered adjusted multiple linear regression models with hierarchical blocks to predict olfactory performance considering β‑weights.
Of the study participants, 4.2% had hypothyroidism and 2.4% had hyperthyroidism. The majority exhibited normal thyroid function. One third (33.5%; 95% confidence interval, CI 29.4-37.0%) were hyposmic. The results indicate no substantial association between thyroid and olfactory functions. Increasing age (β = 0.20), lower performance in the Neuropsychological Test Battery Vienna (NTBV) dimensions verbal memory (β = -0.33) and attention (β = -0.12) appear to be risk factors for lower olfaction. A discrepancy between subjective and objective olfaction was found.
Thyroid and olfactory functions had no substantial relationship. Higher fT4 correlated weakly with lower odor identification. Increasing age and decreased performance in two out of six NTBV dimensions are relevant prognostic factors for olfactory dysfunction.
甲状腺激素可能在认知障碍的不同阶段影响嗅觉,这些阶段包括主观认知下降(SCD)、非遗忘型(naMCI)和遗忘型轻度认知障碍(aMCI)。此外,生物特征参数、抑郁和神经心理学表现被视为可能的影响因素。
在2001年至2023年的观察期内,对维也纳总医院年龄≥50岁的495名(女性占52.3%)SCD、naMCI和aMCI受试者进行了回顾性单中心数据分析。
通过“嗅棒”气味识别客观测量标准嗅觉功能,并通过自我报告嗅觉功能评估测试主观测量。血清甲状腺激素水平,主要是促甲状腺激素,以及T3、T4、游离T3和游离T4,用于评估甲状腺功能。使用IBM SPSS®29.0.0进行的统计分析涵盖了调整后的多元线性回归模型和分层块,以考虑β权重预测嗅觉表现。
在研究参与者中,4.2%患有甲状腺功能减退,2.4%患有甲状腺功能亢进。大多数人甲状腺功能正常。三分之一(33.5%;95%置信区间,CI 29.4 - 37.0%)嗅觉减退。结果表明甲状腺与嗅觉功能之间没有实质性关联。年龄增长(β = 0.20)、维也纳神经心理测试电池(NTBV)维度中言语记忆(β = -0.33)和注意力(β = -0.12)表现较低似乎是嗅觉降低的危险因素。发现主观嗅觉和客观嗅觉之间存在差异。
甲状腺与嗅觉功能没有实质性关系。较高的游离T4与较低的气味识别呈弱相关。年龄增长和NTBV六个维度中的两个维度表现下降是嗅觉功能障碍的相关预后因素。